Annamaria Vezzani

Medicine & Life Sciences

1. Seizures 100%
2. Epilepsy 70%
3. Hippocampus 47%
4. Status Epilepticus 31%
5. Interleukin-1 29%
6. Neuropeptide Y 26%
7. Brain 26%
8. Kainic Acid 24%
9. Quinolinic Acid 21%
10. Somatostatin 19%
11. Anticonvulsants 18%
12. Temporal Lobe Epilepsy 17%
13. Neurons 16%
14. Neuroglia 16%
15. Encephalitis 14%
16. Inflammation 14%
17. Astrocytes 13%
18. Biomarkers 12%
19. Interleukin-1 Receptors 11%
20. Dentate Gyrus 11%
21. Neuropeptide Y Receptors 11%
22. Pharmaceutical Preparations 10%
23. Theoretical Models 10%
24. Microglia 10%
25. Anti-Inflammatory Agents 10%
26. Cytokines 9%
27. Malformations of Cortical Development 9%
28. Blood-Brain Barrier 9%
29. Messenger RNA 8%
30. Therapeutics 7%
31. Epileptic Syndromes 7%
32. Synaptic Transmission 7%
33. Neuropeptides 7%
34. Pharmacology 6%
35. Drug Resistant Epilepsy 6%
36. Rodentia 6%
37. Glutamate Receptors 6%
38. Injections 6%
39. Toll-Like Receptor 4 6%
40. Toll-Like Receptors 6%
41. Genetic Therapy 6%
42. Interleukin 1 Receptor Antagonist Protein 6%
43. N-Methyl-D-Aspartate Receptors 5%
44. aspartic acid receptor 5%
45. N-Methylaspartate 5%
46. Prosencephalon 5%
47. Interleukins 5%
48. Febrile Seizures 5%
49. Glutamic Acid 5%
50. ATP Binding Cassette Transporter, Subfamily B, Member 1 5%